Premium
Ex Vivo and In Vitro Studies on the Cytotoxicity and Immunomodulative Properties of Poly(2‐isopropenyl‐2‐oxazoline) as a New Type of Biomedical Polymer
Author(s) -
Kroneková Zuzana,
Mikulec Marcel,
Petrenčíková Nadežda,
Paulovičová Ema,
Paulovičová Lucia,
Jančinová Viera,
Nosál' Radomír,
Reddy Palem S.,
Shimoga Ganesh D.,
Chorvát Dušan,
Kronek Juraj
Publication year - 2016
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.201600016
Subject(s) - chemistry , oxazoline , ex vivo , cytotoxicity , drug delivery , polymer chemistry , biophysics , in vitro , biochemistry , organic chemistry , biology , catalysis
Poly(2‐alkenyl‐2‐oxazoline)s are promising functional polymers for a variety of biomedical applications, such as drug delivery systems, peptide conjugates, or gene delivery. In this study, poly(2‐isopropenyl‐2‐oxazoline) (PIPOx) is prepared through free‐radical polymerization initiated with azobisisobutyronitrile. Reactive 2‐oxazoline units in the side chain support an addition reaction with different compounds containing a carboxylic group, which facilitates the preparation of polymers labeled with two different fluorescent dyes. The cytotoxicities of 2‐oxazoline monomers, PIPOx, and fluorescently labeled PIPOx are evaluated in vitro using an 3‐(4,5‐Dimethyldiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay and ex vivo using a cell proliferation assay with adenosine triphosphate bioluminescence. The cell uptake of labeled PIPOx is used to determine the colocalization of PIPOx with cell organelles that are part of the endocytic pathway. For the first time, it is shown that poly(2‐isopropenyl‐2‐oxazoline) is a biocompatible material and is suitable for biomedical applications; further, its immunomodulative properties are evaluated.